In vitro models in endocrine disruptor screening.
Charles
Grantley D
GD
Toxicology & Environmental Research & Consulting, The Dow Chemical Company, Midland, MI, USA.
D000826:Animal Testing Alternatives / Q000379:methods*; D000818:Animals; D002478:Cells, Cultured / Q000187:drug effects* / Q000473:pathology; D004702:Endocrine Glands / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D004781:Environmental Exposure / Q000009:adverse effects; D005260:Female; D006727:Hormone Antagonists / Q000145:classification / Q000633:toxicity*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D018675:Toxicity Tests / Q000379:methods*; D014481:United States; D014484:United States Environmental Protection Agency
D006727:Hormone Antagonists